Circulating Endothelial Transcriptomic Signatures Predict Worse Outcomes in COVID-19, Respiratory Failure and ARDS

Highlight

– Elevated circulating endothelial signatures (ECS%) derived by unsupervised bulk-transcriptome deconvolution are higher in non-survivors of respiratory failure in a pediatric cohort (CAF-PINT) and in adults hospitalized with COVID-19 (IMPACC).

– In IMPACC, each 1% increment in baseline ECS% was independently associated with 28‑day mortality (adjusted OR 1.36, 95% CI 1.03–1.79).

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply